California Public Employees Retirement System’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-106,938
Closed -$320K 1196
2023
Q2
$320K Hold
106,938
﹤0.01% 1204
2023
Q1
$370K Sell
106,938
-10,977
-9% -$53.2K ﹤0.01% 1210
2022
Q4
$493K Buy
117,915
+4,637
+4% +$17.6K ﹤0.01% 1211
2022
Q3
$454K Buy
113,278
+25,359
+29% +$192K ﹤0.01% 1209
2022
Q2
$993K Buy
87,919
+34,904
+66% +$418K ﹤0.01% 1194
2022
Q1
$861K Sell
53,015
-99,887
-65% -$2.56M ﹤0.01% 1210
2021
Q4
$7.25M Buy
152,902
+96,859
+173% +$5.81M ﹤0.01% 1101
2021
Q3
$4.06M Buy
+56,043
New +$4.05M ﹤0.01% 1207

Other funds holding NBP

California Public Employees Retirement System's NBP Position: Q3 2023 in Review

California Public Employees Retirement System sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 106,938 shares — an estimated $320K sold.

California Public Employees Retirement System first reported a position in NBP in Q3 2021 and held it in 8 quarters. The position peaked at $7.25M in Q4 2021. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

  • California Public Employees Retirement System reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • California Public Employees Retirement System sold 106,938 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $320K.
  • California Public Employees Retirement System first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 8 quarters.
  • California Public Employees Retirement System's NovaBridge Biosciences American Depositary Shares position peaked at $7.25M in Q4 2021.
  • 47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on California Public Employees Retirement System's 13F filing for Q3 2023, filed 2 Nov 2023.